Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E42
DOI: 10.3816/clm.2009.n.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Carmen Fava und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fava, C., Ulisciani, S., Giugliano, E., Brunetto, V., Gottardi, E., Giaretto, L., Saglio, G., & Rege-Cambrin, G. (2009). Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation. Clinical Lymphoma and Myeloma, 9(6), E42. https://doi.org/10.3816/clm.2009.n.103
Vancouver
Fava C, Ulisciani S, Giugliano E, Brunetto V, Gottardi E, Giaretto L, et al. Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation. Clinical Lymphoma and Myeloma. 2009;9(6):E42. doi:10.3816/clm.2009.n.103
BibTeX
@article{Fava2009,
author = {Fava, Carmen and Ulisciani, Stefano and Giugliano, Emilia and Brunetto, Vanessa and Gottardi, Enrico and Giaretto, Lorena and Saglio, Giuseppe and Rege-Cambrin, Giovanna},
title = {Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {E42},
doi = {10.3816/clm.2009.n.103}
}
EUVIMED